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Abstract
Background: Calcium supplementation during pregnancy has been shown to reduce the incidence of pre-eclampsia/
eclampsia among women with low calcium intake. Universal free calcium supplementation through government
antenatal care (ANC) services was piloted in the Dailekh district of Nepal. Coverage, compliance, acceptability and
feasibility of the intervention were evaluated.
Methods: Antenatal care providers were trained to distribute and counsel pregnant women about calcium use, and
female community health volunteers (FCHVs) were trained to reinforce calcium-related messages. A post-intervention
cluster household survey was conducted among women who had given birth in the last six months. Secondary data
analysis was performed using monitoring data from health facilities and FCHVs.
Results: One Thousand Two hundred-forty postpartum women were interviewed. Most (94.6 %) had attended at least
one ANC visit; the median gestational age at first ANC visit was 4 months. All who attended ANC were counseled
about calcium and received calcium tablets to take daily until delivery.79.5 % of the women reported consuming the
entire quantity of calcium they received. The full course of calcium (300 tablets for 150 days) was provided to 82.3 %
of the women. Consumption of the full course of calcium was reported by 67.3 % of all calcium recipients. Significant
predictors of completing a full course were gestational age at first ANC visit and number of ANC visits during their
most recent pregnancy (p < 0.01). Nearly all (99.2 %) reported taking the calcium as instructed with respect to dose,
timing and frequency. Among women who received both calcium and iron (n = 1,157), 98.0 % reported taking them
at different times of the day, as instructed. Over 97 % reported willingness to recommend calcium to others, and said
they would like to use it during a subsequent pregnancy. There were no stock-outs of calcium.
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Conclusions: Calcium distribution through ANC was feasible and effective, achieving 94.6 % calcium coverage of
pregnant women in the district. Most women (over 80 %) attended ANC early enough in pregnancy to receive the full
course of calcium supplements and benefit from the intervention. High coverage, compliance, acceptability among
pregnant women and feasibility were reported, suggesting that this intervention can be scaled up in other areas of
Nepal.
Keywords: Calcium, Pre-eclampsia, Eclampsia prevention, Maternal health, Coverage, Compliance, Acceptability,
Feasibility, Antenatal care
Abbreviations: ANC, Antenatal care; DHS, Demographic and Health Survey; FCHV, Female Community Health
Volunteer; HMIS, Health Management Information System; MCHIP, Maternal and Child Health Integrated Program;
MICS, Multi-Indicator Cluster Survey; MOHP, Minister of Health and Population; PE/E, Pre-eclampsia/eclampsia;
VDC, Village Development Committee
Background
Pre-eclampsia/eclampsia(PE/E) and other hypertensive
disorders during pregnancy cause 14 % of maternal
deaths globally [1]. The incidence of pre-eclampsia is es-
timated at 3.2 % of live births, or a total number of more
than four million cases each year, of which more than
72,000 were fatal [2]. Hypertensive disorders can also
result in pre-term birth, a leading cause of neonatal
mortality [3]. There are no reliable predictive tests for
the development of pre-eclampsia or the progression to
eclampsia [4], so greater attention is being given to inter-
ventions to prevent PE/E. Recent clinical trials indicate
that calcium supplementation with doses of at least 1 g of
elemental calcium per day during pregnancy more than
halved the risk of pre-eclampsia [5]. The World Health
Organization recommends calcium supplementation for
all women in areas where dietary calcium intake is low
and for those at high risk of developing pre-eclampsia [6].
In Nepal, as the maternal mortality ratio has de-
creased, eclampsia has become the leading cause of ma-
ternal deaths [7], replacing postpartum hemorrhage. To
try to address the problem, the Nepal Ministry of
Health and Population (MOHP) has evidence-based
clinical standards in place for PE/E screening during
antenatal care (ANC) (i.e., routine urine testing for pro-
tein; blood pressure measurement) and PE/E manage-
ment at all health facilities. ANC attendance in Nepal
increased from 49.1 % in 2001 [8] to 84.8 % in 2011 [9]
for at least one visit. In 2011, almost half of ANC clients
(49.7 %) came for their first visit before 4 months, and
50.1 % of women who had recently delivered attended
the recommended four or more ANC visits [9], indicat-
ing increasing opportunities to screen and treat women
for PE/E during pregnancy. The MOHP and national
stakeholders recognize there is a lack of information on
calcium deficiency among women in Nepal and a
greater need for calcium during pregnancy and while
breastfeeding to prevent PE/E and preterm births and
to address maternal under nutrition [10].
As the MOHP explored the possibility of introducing
calcium supplementation during pregnancy, they found
a lack of programmatic evidence about the best approaches
for reaching pregnant women and the acceptability of
supplements among pregnant women and their fam-
ilies. Acceptance of and compliance with daily calcium
consumption among pregnant women outside of clinical
trials were unknown. The MOHP, with assistance from
the Maternal and Child Health Integrated Program
(MCHIP) and Jhpiego, therefore designed an operations
research study in one district of Nepal to evaluate whether
integration of free calcium supplementation with existing
government ANC services was feasible and effective.
Jhpiego, an international non-profit health organization af-
filiated with the Johns Hopkins University, is working in
Nepal to support Ministry of Health (MoH) especially in
maternal health. The primary objectives of the study were
to assess the coverage, compliance, acceptability and
feasibility of the antenatal calcium supplementation
intervention. The study was not designed to measure
the incidence of PE/E or clinical efficacy of calcium
supplementation, given the clinical evidence already
documented [3]. Rather, it was intended to generate in-
formation to inform policy decisions by the MOHP re-




Dailekh district, a large hill district in the Bheri zone of
the Mid-western Region of Nepal, was selected for the
study by the Family Health Division of the MOHP in
consultation with a technical advisory group. The
population is about 261,770, with approximately 48,919
households, 63,073 women of reproductive age, and
7407 expected pregnancies per year [11, 12]. Dailekh
has 55 village development committees (VDCs) and
one municipality. There is a mix of castes/ethnicities,
including highly disadvantaged Dalit, disadvantaged/
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Janajati and upper caste groups. There are government
health facilities and 810 female community health vol-
unteers (FCHVs) in Dailekh [12].
The intervention
ANC was selected as the mechanism for counseling and
distribution of calcium to pregnant women in light of
the relatively high ANC attendance in Nepal as well as
logistical considerations. While Nepal has a strong network
of more than 48,000 FCHVs [12] who deliver maternal
health information and products (e.g., iron folate supple-
ments, misoprostol) to women at home, calcium is a bulky
commodity that would be logistically problematic for
FCHVs to carry, given the quantity required for antenatal
supplementation.
The antenatal calcium supplementation intervention
was defined as follows: (1) education and counseling
about PE/E and calcium for all pregnant women who at-
tend ANC (primarily during the first ANC visit), (2)
provision of enough calcium carbonate tablets to last for
5 months or until the end of their pregnancies to all
pregnant women during ANC, and (3) consumption by
pregnant women of a daily dose of 1 g of elemental cal-
cium (two tablets of 500 mg each) beginning at 4 months’
gestation (i.e., the timing of the first ANC visit as recom-
mended by the MOHP and the median months’ gestation
in the 2011 Nepal Demographic and Health Survey) for
5 months (150 days) or until delivery. Women were
instructed to take two tablets (dose) once daily (frequency)
in the morning (timing) for five months (duration). The
daily dose of 1 g was based on the trials included in the
2010 Cochrane review available during study design [3].
Because of concerns that calcium might interfere with iron
absorption [13], the women were instructed to take the
calcium tablets after their morning meal (whereas iron
was to be taken with the evening meal) and not to take it
with iron. FCHVs were also expected to counsel pregnant
women about calcium supplementation during their visits
with them.
District implementation
Calcium carbonate is registered with the Department of
Drug Administration but is not on the national Essential
List of Medicines. Jhpiego procured 26,500 bottles of cal-
cium, each containing 100 tablets of calcium carbonate
US Pharmacopeia (1250 mg equivalent to 500 mg/tablet
of elemental calcium). Calcium was purchased first from
Missionpharma India (US$ 0.01/tablet or Nepali Rupees
0.65/tablet) and then from Curex Pharmaceuticals Nepal
(US$ 0.016/tablet or Nepali Rupees 1.35/tablet). Both
shipments were delivered to the district health office, en-
tered into the logistics management information system,
and distributed to health facilities. Procured calcium was
packaged in 100-tablet bottles, so three bottles was the
standard amount distributed to women attending ANC
at 4 months (total of 150 doses of 1 g elemental calcium
each).
A district-level orientation was conducted for gov-
ernment district officials and health staff from non-
governmental organizations. All government health
workers who provide ANC or supervise ANC staff
(n = 268) and all FCHVs in the district (n = 810) were
trained for 1 day by MOHP and MCHIP/Jhpiego
staff. An educational poster about calcium supple-
mentation during pregnancy was provided to all
health facilities, and the birth preparedness package
flipchart used by FCHVs was supplemented with an
additional page of calcium messages.
After training, ANC providers began to educate preg-
nant women and distribute calcium, primarily during
the first ANC visit. The intervention continued for a 14-
month period from June 2012 to August 2013. The
number of calcium bottles distributed to a pregnant
woman was based on gestational age at her first ANC
visit and the remaining period of her pregnancy (i.e., a
pregnant woman coming at the 4th or 5th month of ges-
tation was provided 300 tablets; those coming at 6 or
7 months were given 200 tablets; and those who came at
8 or 9 months received 100 tablets). The full supply of
calcium was distributed at one visit in a small bag with
an educational brochure. FCHVs met with pregnant
women in their catchment area in the course of their
normal duties, and were expected to encourage them to
make ANC visits and also to educate them about cal-
cium. FCHVs recorded basic information on calcium
consumption during the postpartum visits they routinely
conducted.
Monitoring of this intervention was integrated into the
existing health management information system (HMIS).
FCHV record forms were modified to capture informa-
tion on calcium. A new calcium register was introduced
to record distribution by ANC providers.
The district health office staff, with the support of
two Jhpiego/MCHIP district-based staff, conducted
periodic technical support visits to health facilities
and FCHVs to monitor implementation of the pro-
gram, reinforce key messages and address data collec-
tion issues. Updates were provided to the MOHP and
the technical advisory group throughout the study to
inform plans for national rollout.
Study design
The study consisted of two components: prospective col-
lection and secondary analysis of monitoring data cap-
tured by the MOHP through the district HMIS and a
post-intervention household survey of women who had
delivered in the last 6 months, or “recent mothers.”
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Sampling
Sample size calculations for the household survey of
postpartum women were based on estimating ANC
coverage in the general population of pregnant women
and among women who received calcium, as well as
compliance with the recommended calcium regimen
among women who received calcium. Calculations used
a one-sample proportion with high precision (5 %), in-
cluding a design effect of 2 for the cluster design and an
estimated nonresponse rate of 10 %. A total sample of
1230 postpartum women was required to achieve the de-
sired degree of precision.
The household survey employed a three-stage cluster
sampling approach to select women who had given birth
in the last 6 months: the first stage selected VDCs ran-
domly and the second stage using selected wards (nine
wards per VDC; an average of 97 households per ward
and an average of 5.3 persons per household) as the
units of clustering. From the list of clusters, 62 clusters
were chosen following the probability proportional to
population method, with a target of 20 postpartum
women per cluster to achieve a total of 1240. The inter-
viewers visited every household of the sampled cluster to
interview an eligible woman which entailed visiting an
average of 10.4 households to find eligible woman.
Data collection
Data from health facilities and FCHVs were collected
monthly and analyzed to determine whether calcium
was being distributed through ANC and consumed
regularly by women. Data on pregnancy, delivery and
calcium use collected on a monthly basis through FHCV
registers and then summarized on health worker reporting
forms were aggregated in monthly health facility reporting
forms.
Post-intervention household interviews were conducted
in August 2013 with women who had given birth in the last
6 months to measure overall calcium coverage, compliance
with and acceptability of the recommended calcium
regimen, along with ANC coverage. The questionnaire
included the standardized Nepal DHS formulation of
questions that were relevant to the calcium study. It
was pretested and revised before data collection.
For the household survey, courtesy bias was mini-
mized by hiring a local independent research agency,
Population, Health and Development Group, instead
of using project staff or government health officials,
to conduct the interviews. The agency hired 24 field
researchers, of whom 15 were women, who all re-
ceived 1 week of training on maternal health, calcium
intervention, study objectives, methodology and inter-
view techniques. Training also included ethical consid-
erations, mechanisms and techniques for confronting
and overcoming their own biases, ways of administer-
ing specific questions, and probing strategies.
Study measures
Information on compliance with the recommended cal-
cium consumption regimen was captured in two ways.
First, FCHVs conducted a tablet count at the end of
pregnancy as part of routine monitoring. Second, we
collected information on self-reported compliance in the
household survey. The household survey also gathered
information on correct dose, timing and frequency and
duration of calcium consumption. Self-reporting is the
international standard for measuring iron coverage and
consumption through the DHS and the Multi-Indicator
Cluster Survey (MICS) international household survey
programs and thus it was the key method used in this
study to measure calcium coverage and consumption
during pregnancy.
Self-reported duration of calcium consumption also
was measured. The number of days calcium was con-
sumed was divided into three categories: a full course
(150 days or 300 tablets), a partial course (90–149 days
or 180–298 tablets), and short course (fewer than 90 days
or less than 180 tablets). The number of days was deter-
mined using the responses from postpartum women
who consumed calcium during their last pregnancy by
asking, “How many days did you take calcium tablets
during your last pregnancy?”
Data analysis
A secondary analysis of the subset of the data in the
health facility reporting forms, which is a compilation of
the FCHV data, was entered into a database in Epi-Info
and analyzed.
Descriptive analyses of the household survey data,
including frequencies, means, medians and cross-
tabulations using Pearson’s chi-square tests of signifi-
cance, were conducted using SPSS v17. A p-value of
0.05 was used to determine statistical significance.
Weights were applied to the sample to adjust for the
urban/rural distribution of the population in Dailekh
district [11], using the same procedure used in the
Nepal DHS [8]. Multivariate logistic regression models,
using robust (Huber-White) variance estimates that ac-
count for clustering, were fit to obtain the estimates in
Table 5, using R statistical software v3.0.2 [14, 15]. In-
dependent variables included in the multivariate ana-
lyses were the same as those that were included in the
bivariate analyses, such as variables pertaining to per-
sonal characteristics of pregnant women that are
known from the literature to affect health behavior in
Nepal or other countries.
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Ethical approval
Ethical approval was obtained from Nepal Health Research
Council and the Johns Hopkins University Bloomberg
School of Public Health institutional review board. In-
formed verbal consent was obtained from the respondents
to participate in the study.
Results
Sample characteristics
A total of 8641 pregnancies were expected for the 14-
month program period (extrapolated from census data)
[11]. The MOHP HMIS recorded 9246 pregnant women
who came for ANC and received calcium. Women were
mainly (98.8 %) from Dailekh district.
For the household survey, a total of 1240 postpartum
women were interviewed, after screening 12,901 house-
holds. Study participants lived predominantly in rural
areas, had low educational status (39 % with no educa-
tion), were young (median age of 23), and were primarily
of the Chhetri/Thakuri and Dalit castes (Table 1).
Coverage of ANC and delivery services
Among the 1240 women interviewed in the household
survey, 1173 (94.6 %) attended at least one ANC visit at
a health facility during their last pregnancy. The median
gestational age at the first ANC visit was 4 months
(mean of 4.28 months). Most of the women (70.7 %)
made four or more ANC visits during their most recent
pregnancy. Urban women were more likely than rural
women to attend ANC four or more times (90.0 % and
69.0 %, respectively). ANC was provided by a skilled
provider (a doctor, nurse, to auxiliary nurse midwife) for
82.1 % of the women (Table 2).
Calcium coverage
All the women who attended ANC 1240 (100.0 %) were
counseled on calcium use and received calcium. Calcium
coverage (supplement distribution) therefore was 1173
(94.6 %) of all women surveyed. Among the women who
received calcium (n = 1173), 965 (82.2 %) reported that
they received 300 tablets, 161 (13.8 %) said they received
200 tablets, and 47 (4.0 %) reported receiving only 100
tablets (one bottle). A total of 73.0 % of the women who
received calcium reported taking calcium beginning in
the 4th month of pregnancy (Table 3). A total of 1157
women (93.3 %) received both calcium and iron.
Compliance with calcium intake instructions
Compliance with the recommended calcium supplemen-
tation instructions was examined by dose (two tablets),
timing (after the morning meal), and frequency (daily).
Among the women who received calcium, 99.2 %
(n = 1164) reported taking the correct dose with the correct
timing and frequency. Of the 1157 women who received
both calcium and iron supplements, 99.8 % (n = 1155) re-
ported taking them at separate times of the day, as
instructed.
Compliance was further analyzed by the amount of
calcium consumed. A full course is defined as 150 days
(all 300 tablets), a partial course as 90–149 days (180–
298 tablets), and a short course as less than 90 days (less
than 180 tablets). Among the 1173 women who received
calcium, 790 (67.3 %) reported that they completed a full
course, 283 (24.1 %) reported taking a partial course,
and100 (8.6 %) reported taking a short course. Full com-
pliance for the intervention therefore was 67.3 %. For
comparison, compliance data recorded by FCHVs as part
of the regular program monitoring, were analyzed for
the previous 6 months (the period covered by the sur-
vey). FCHV-reported data were consistent with the sur-
vey results: full course 67.6 %, partial course 22.7 %, and
short course 8.4 %.
Ability to complete the full course was dependent on
the gestational age at the time of calcium distribution
(i.e., whether the pregnant woman received 300 tablets
and had enough days before delivery to consume them
all). Consumption was analyzed by the quantity of calcium
received, and 91.4 % of women who received calcium con-
sumed the entire course they were given. Among the 965
women who received the full course of calcium, 916
(73.8 % of all women surveyed) were in their 3rd or 4th
Table 1 Socio-demographic characteristics of women
interviewed (n = 1240)
Characteristic Number Percentage
Residence
Rural 1140 91.9 %
Urban 100 8.1
Age (in years)
< 20 218 17.6
20–34 948 76.5
35–49 75 6.1




Some secondary 338 27.3






aCaste/ethnicity stratification is a major determinant of people’s identity and
social status in Nepalese society
bJanajati includes three Muslim groups and one Terai middle caste group
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month of pregnancy, so they could complete the full
course of 150 days of calcium (Table 3). Among these, 768
women (83.8 %; n = 768/916) reported that they consumed
the full course of 300 tablets in 150 days (Table 4). There-
fore, 61.9 % (n = 768/1240) of women received the inter-
vention as it was designed (i.e., effective coverage defined
as daily consumption of 1 g of calcium for 150 days during
pregnancy).
There was some variation in calcium consumption by
socio-demographic characteristics of the respondents and
the gestational age at which they received and started tak-
ing calcium (Table 4). Cross-tabulations using a chi-square
statistical test revealed significant differences in consump-
tion by the mother’s age, education and gestational age at
which calcium consumption began. A slightly higher
proportion of women ages 20–29 and 30–45 than those
less than 20 years of age completed a full course of cal-
cium. A smaller proportion of women with no education
than women with any education completed a full course
of calcium. Caste did not appear to have any effect on
calcium consumption.
Multivariate regression analyses were performed to
further explore predictors of compliance with the rec-
ommended calcium intake regimen. These analyses were
restricted to only those women who started taking cal-
cium at 5 months or earlier in their pregnancy, so they
could conceivably complete the recommended full
course of calcium supplementation during pregnancy.
Table 5 shows the results of the final multivariate lo-
gistic regression model, which includes all the covari-
ates shown in the table, with each covariate adjusted for
all the other covariates. The reference category for age
is <20 years old. “Months pregnant” and “number of
ANC visits” are modeled linearly as continuous vari-
ables. The reference category for “urban” residence is
“rural” residence and the reference category for “educa-
tion” is some, non-zero school attendance. The final
model found that two variables are significant predic-
tors of completing a full course (150 days) of calcium:
gestational age at first ANC visit and total number of
ANC visits attended. The estimated odds of completing
a full course decreased with increasing gestational age,
and increased as the total number of ANC visits in-
creased. After adjusting for the other predictors in the
model, the age of the mother was not found to be sta-
tistically significant, whether modeled as a linear ef-
fect, a linear effect with linear splines, or in three
categories (<20, 20–29 and >30). Other multivariate
models (data not shown) fit caste group as a pre-
dictor and included education modeled as a continu-
ous linear predictor and in neither case did results
change in the direction of any of the effect estimates
or their statistical significance or non-significance.
The size of the effect estimates also remained fairly
consistent regardless of any of these changes with
age, caste and education.
Discontinuation
About 10 % (n = 120) of the postpartum women said they
stopped taking the calcium tablets before giving birth. The
following reasons for discontinuation were reported: they
became sick/ill (considered by the woman to be unrelated
to calcium) they experienced side effects; they forgot to
take the calcium; they found it difficult to take the tablets
because they are too big; and they found it inconvenient
to take the tablets every day.
Table 2 Coverage of ANC and delivery services among women interviewed
Characteristic Number Percentage
ANC among all women surveyed (n = 1240)
Attended at least one ANC visit 1173 94.6
Attended at least one ANC visit with a skilled provider 1017 82.1
Attended four or more ANC visits 877 70.7
Urban (total n = 100) 90 90.0
Rural (total n = 1140) 785 69.0
Delivery care among women receiving calcium (n = 1173)
Institutional delivery among women who received calcium 785 67.0
Table 3 Amount of calcium received by gestational age at start
of taking calcium (n = 1173)
Gestational age
at start of taking
calcium
Amount of calcium received
100 Tablets 200 Tablets 300 Tablets
Number % Number % Number %
Month 3 (n = 88) 0 0 2 0.2 86 7.3
Month 4 (n = 856) 4 0.3 22 1.9 830 70.8
Month 5 (n = 60) 0 0 15 1.3 45 3.8
Month 6 (n = 118) 7 0.6 107 9.1 4 0.3
Month 7 (n = 31) 19 1.6 12 1 0 0
Month 8 (n = 17) 14 1.2 3 0.3 0 0
Month 9 (n = 3) 3 0.3 0 0 0 0
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Knowledge about calcium and acceptability among
postpartum women
Among all of the postpartum women who received cal-
cium at ANC (n = 1173), 98.9 % (n = 1160) responded
that pregnant women should take both iron and calcium
tablets during pregnancy. Over 98 % of the women cor-
rectly answered questions on dose, timing, frequency
and duration.
Several questions were included in the survey to assess
the acceptability of calcium. Of the postpartum women
who consumed any calcium (n = 1173), 983 (83.9 %)
found the taste of the calcium acceptable; 1148 (97.9 %)
would take calcium again in a future pregnancy; and
1144 (97.5 %) would recommend calcium to other preg-
nant women.
The study also examined whether ANC clients were
routinely screened for PE/E. Among women who attended
ANC and received calcium (n = 1173), 1150 (98.0 %) re-
ported that they had their blood pressure measured at
least once during ANC, and 1006 (85.7 %) had it taken at
every ANC visit. Similarly, 1138 (97.0 %) said they had a
urine test at least once, and 797 (67.9 %) said their urine
was tested at every ANC visit.
Feasibility of the intervention
There were no stock-outs of calcium reported, and all
who attended ANC received calcium. By design, calcium
was distributed at one visit to avoid issues with re-
supply. Only 16 (1.4 %) of calcium consumers reported
having difficulty storing the calcium. FCHVs were trained
Table 4 Bivariate analysis of reported amount of calcium consumption by background characteristics of postpartum women
household survey respondents (n = 1173)a
Background characteristics Amount of calcium consumption (%)
Full course Partial course Short course
(150+ days) (90–149 days) (<90 days)
Age
< 20 (n = 208) 62.0 29.3 8.7
20–29 (n = 898) 69.0 22.7 8.2
30–45 (n = 67) 61.2 26.9 11.9
Residence
Rural (n = 1075) 66.4 24.9 8.7
Urban (n = 98) 76.5 15.3 8.2
Education**
No education (n = 443) 63.9 24.2 12.0
Primary (n = 227) 69.0 25.8 5.2
Some secondary (n = 328) 68.3 25.0 6.7
School leaving certificate and above (n = 175) 71.8 20.1 8.0
Gestational age received calcium***
Month 3 (n = 88) 87.5 9.1 3.4
Month 4 (n = 856) 80.7 15.4 3.9
Month 5 (n = 60) 35.6 55.9 8.5
Month 6 (n = 118) 0.0 82.4 17.6
Month 7 (n = 31) 0.0 30.0 70.0
Month 8 (n = 17) 0.0 16.7 83.3
Month 9 (n = 3) 0.0 0.0 100.0
Caste/ethnicity
Chhetri/Thakuri (n = 508) 68.6 23.8 7.7
Bahun/Sanyasi (n = 131) 67.9 24.4 7.6
Janajati (n = 134) 65.7 26.9 7.5
Dalit (n = 400) 66.0 23.5 10.5
Total (1173) 67.3 24.1 8.6
**p < .01, ***p < .001
aP-values are based on Pearson’s chi square test of significance
Thapa et al. BMC Pregnancy and Childbirth  (2016) 16:241 Page 7 of 10
to provide education about calcium. A total of 953 of 1168
women (81.4 %) who received calcium (excluding five who
were FCHVs) reported that FCHVs had visited them at
least once during their last pregnancy. More than 99 %
said they had received information on calcium use, iron
use and ANC from the FCHV during these visits.
Discussion
Overall, distribution of calcium through ANC services
produced very high coverage of calcium supplementa-
tion among pregnant women—95 % of all postpartum
women surveyed received calcium—along with high
compliance—67 % of women who received calcium
(61.9 % of all women surveyed) took the full course
(Fig. 1). Moreover, the vast majority of all women who re-
ceived calcium reported that they took it as instructed
with respect to dosage, frequency and timing. This inter-
vention was designed to provide 1 g of calcium daily
for a total of 5 months, estimating that this amount,
starting in the 4th month of pregnancy after the nau-
sea of pregnancy had subsided, would take the client
to term. The final regression analysis identified two
significant predictors of completing a full course: ges-
tational age at first ANC visit and number of ANC
visits. These findings are logical in the sense that a
greater number of ANC visits increases opportunities
for additional education and reminders. In order to
increase consumption of the full course of calcium to
give pregnant women the maximum benefit from the
intervention, calcium could be distributed at ANC
visits in the first trimester, and consumption could be
encouraged as early as feasible.
Table 5 Multivariate logistic regression analysis of predictors of a full course of calcium intake (150 Days) among women starting
calcium by 5th month of pregnancy (n = 1036)b
Characteristics Odds Ratio
(Estimate)
95 % C I for ODDS ratio Significance level
lower upper P-value
Age 20–29 1.30 0.86 1.97 0.22
Age 30–45 1.12 0.66 1.92 0.67
No education 1.27 0.88 1.84 0.20
Month pregnant when made first ANC visita 0.42 0.30 0.61 0.00*
Number of ANC visitsa 1.74 1.36 2.21 0.00*
Urban 0.79 0.51 1.23 0.30
*p < .001
acontinuous variables
bP-values are based on Wald test results, and are based on the coefficient z-scores from the multivariate logistic regression, using robust (Huber-White) sandwich
estimates of variance
Fig. 1 Flowchart of Calcium Distribution and Consumption
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Surprisingly, ANC attendance in Dailekh was found to
be higher than anticipated: 94.6 % of women made one
ANC visit, and the proportion of women attending four
or more ANC visits was much higher in Dailekh
(70.7 %) than is reported nationally (50.1 %) [9]. The
high coverage documented may be due to the fact that
there were few private sector providers of maternal
health service, so the government ANC platform proved
to be the only option for ANC services. Likewise, the
MOHP incentives for pregnant women to attend ANC
provided by the Maternity Incentive Scheme might have
contributed to the number of ANC visits early in preg-
nancy. With calcium in stock, ANC providers provided
education and distributed calcium to 100 % of women
attending ANC, demonstrating the feasibility of integrat-
ing calcium supplementation with ANC, without over-
burdening health care workers. The amount of calcium
distributed correlated well with the gestational age of
the pregnancy at the ANC visit during which the re-
spondents received the calcium. Most of the women
(73.8 %) received the full course of calcium by the 4th
month of pregnancy, which allowed them enough time
to consume the recommended course before birth. En-
couragingly, nearly all women (99.8 %) who received
both calcium and iron tablets reported taking them at
separate times of day, so adverse effects of calcium sup-
plementation on iron consumption and absorption were
not of concern.
The majority of women (91.4 %) consumed all the cal-
cium they received, and this high rate of compliance
may have been due to the combined effects of proper
counseling during ANC visits about the benefits of cal-
cium in pregnancy; educational information received
through multiple channels (poster, brochures, FCHVs);
MOHP incentives for pregnant women to attend ANC
early in pregnancy; and, potentially, the well-established
FCHV-led iron distribution efforts in Nepal, which may
have made taking a supplement familiar and acceptable
to pregnant women.
Regarding the 10 % of the women surveyed who dis-
continued use of the calcium supplements, this level
of discontinuation suggests a need for more strategic
behavior change communication interventions at the
community level, such as regular reminders from FCHVs
or mobile text messages. Despite concerns about the size
of the tablets, the chalky taste and the need to take mul-
tiple pills each day, calcium was found to be acceptable to
pregnant women.
The overall design of the intervention was found to be
feasible given that 100 % of clients making ANC visits
were provided calcium during ANC; screening services
were regularly provided at ANC visits; women reported
no problem with storing calcium; and FCHVs and health
workers played their roles well. The challenge moving
forward may be procurement of the supplements at an
affordable price.
There are several limitations to this study. Self-
reported household survey data can be subject to recall
bias; however, the recall period for questions pertaining
to ANC experience was much shorter (up to 6 months)
in this study than in international household surveys
such as the DHS, which has a recall period of up to
5 years, and the MICS, with a recall period of up to
2 years. Thus, the quality of the self-reported household
survey data in this study was expected to be high. Re-
ported compliance was also verified with monitoring
data collected by FCHVs. Data such as socioeconomic
characteristics were not collected on women who did
not attend ANC. The study was not designed to (1) col-
lect serum calcium level (bio-marker) data to validate
self-reported consumption; (2) collect qualitative data
to explain the reasons for discontinuation or for late
ANC attendance; or (3) measure the reduction in PE/E
prevalence in the population.
When this study was designed, there was limited evi-
dence on the minimum effective dose and duration of
calcium supplementation. Recent recommendations sug-
gest the daily dose may be reduced (e.g., 1.0–1.5 elemental
calcium/day or 500–600 mg if high-dose supplementation
isn’t feasible) and should be divided for ≤500 mg per dose
[16–18]. This would prove significant in halving commod-
ity costs, reducing storage needs and easing consumption.
Omotayo et al. also suggest calcium and IFA pills be taken
together to simplify patient instructions and improve
adherence [16].
Conclusions
This study found calcium supplementation during preg-
nancy, distributed through ANC, achieved the high levels
of coverage and compliance. It was acceptable to pregnant
women and feasible for the district public health system to
distribute through existing public health facilities and
health workers. These findings suggest the intervention
can be expanded through ANC in Nepal. However, more
efforts are needed to encourage pregnant women to at-
tend ANC earlier to receive the full course of calcium
supplementation.
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